Robert Balfour
Chief Executive Officer at Promatix, Inc.
Profile
Robert Balfour is currently the Chief Executive Officer at Promatix, Inc. and an Investment Director at Alsa Management Services Ltd.
He holds a doctorate degree from Imperial College London and an undergraduate degree from Southampton Business School.
Robert Balfour active positions
Companies | Position | Start |
---|---|---|
Alsa Management Services Ltd
Alsa Management Services Ltd Investment ManagersFinance Alsa Management Services Ltd (ALSA Ventures) is a venture capital firm founded in 2018. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 01/07/2018 |
Promatix, Inc.
Promatix, Inc. Data Processing ServicesTechnology Services Promatix, Inc. is based in London, UK. The British company takes a data-driven approach by utilizing a confluence of multi-omic datasets and proprietary algorithms. Promatix, Inc. is a company that was founded to accelerate the process of novel target and drug discovery for cancer patients. The company was founded in 2020, and Robert Balfour has been the CEO of the company since 2021. | Chief Executive Officer | 01/03/2021 |
Training of Robert Balfour
Imperial College London | Doctorate Degree |
Southampton Business School | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Alsa Management Services Ltd
Alsa Management Services Ltd Investment ManagersFinance Alsa Management Services Ltd (ALSA Ventures) is a venture capital firm founded in 2018. The firm is headquartered in London, United Kingdom. | Finance |
Promatix, Inc.
Promatix, Inc. Data Processing ServicesTechnology Services Promatix, Inc. is based in London, UK. The British company takes a data-driven approach by utilizing a confluence of multi-omic datasets and proprietary algorithms. Promatix, Inc. is a company that was founded to accelerate the process of novel target and drug discovery for cancer patients. The company was founded in 2020, and Robert Balfour has been the CEO of the company since 2021. | Technology Services |
- Stock Market
- Insiders
- Robert Balfour